New Trial to Test Implantable Pacemaker for Serious Depression

Article

(NEW YORK)Researchers at 20 leading medical centers in the US are testing a pacemaker-like device that may ease the symptoms of depression. Cyberonics, Inc., the device manufacturer, is currently awaiting approval form the Food and Drug Administration to begin clinical trials. The implanted device will stimulate a nerve that runs down the side of the neck. The nerve will be stimulated for 30 seconds, stop for 5 minutes, and begin again. Side effects of the stimulation include voice change, a sense that something is in the patient's mouth, and difficulty breathing during vigorous activity. For more information visit www.abcnews.com.

Related Videos
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Vaccine conspiracy theory vector illustration word cloud  (Adobe Stock 460719898 by Colored Lights)
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Infection Control Today Topic of the Month: Mental Health
Infection Control Today's topic of the month: Mental Health
Related Content